Fig. 3From: PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinomaCorrelation of serum PIVKA-II and AFP levels in HCC patients using the non-parametric Spearman’s rank correlation analysisBack to article page